Lynette Hammond Gerido (pronounced JARED-O) is an Assistant Professor in the Department of Bioethics at ºÚÁϳԹÏÍø (ºÚÁϳԹÏÍø). Prior to joining ºÚÁϳԹÏÍø, Dr. Gerido completed a postdoctoral research fellowship at the University of Michigan School of Public Health. She received a PhD at Florida State University School of Information, an MPH at Drexel University, and an MBA at George Washington University, where she became immersed in translational health communications and technology policy research. She spent a summer abroad studying public-private partnerships in universal healthcare systems at the Federal University of Bahia (UFBA), Brazil. Dr. Gerido has industry experience in technical program management, software engineering, web development, and visual communications for various federal and academic teams. She has found that embedding bioethical frameworks into the development and application of trustworthy medical technologies, clinical informatics, data science, and health communications improves translation and overall health outcomes for all.
Research Information
Research Interests
Dr. Gerido partners closely with communities in research projects to inform clinical practice, technological design, and policy development. She leverages population-level data to visualize trends and explore the ethical implications associated with clinical research, public health initiatives, and consumer health technologies. Employing mixed methods, her work reveals critical information and communication needs of patients and their families.
Artificial Intelligence (AI)
Dr. Gerido’s research interests further include examining the bioethics of big datasets, natural language processing, artificial intelligence, and large language models. She is dedicated to embedding ethical frameworks and best practices into research and clinical application of these emerging technologies, ensuring they benefit individuals and communities responsibly. This project involves an AI-augmented, ethically grounded framework to enhance the identification, risk stratification, and clinical management of individuals with inherited cancer risk. We aim to transform how diverse data—ranging from clinical records and family history to imaging and genomics—is harmonized and applied through interdisciplinary collaboration among clinicians, genetic counselors, radiologists, AI developers, and patients.
Cancer
Dr. Gerido conducts research exploring how families affected by cancer discuss and share family health history and their decision-making processes regarding genetic testing for hereditary cancers. This research aims to better understand familial communication patterns and decision-making dynamics to improve support resources and inform clinical counseling practices. Dr. Gerido’s scholarly contributions extend to the research utilization of state cancer registries for population genomic research. She examines how cancer registry data can ethically inform genomic research, precision medicine, and clinical improvements. Her work addresses ethical standards and best practices in translating registry-derived data into clinical outcomes, ensuring responsible advancement in cancer care and genomic medicine.
Newborn Screening
Dr. Gerido leads research on Newborn Screening (NBS), a critical public health strategy aimed at identifying and treating serious health conditions in infants before symptoms manifest. In collaboration with First Year Cleveland and healthcare providers in Cuyahoga County, she directed a pilot study funded by the Clinical and Translational Science Collaborative (CTSC). This project involved workshops and surveys with midwives, doulas, nurses, and community health workers to identify gaps in professional awareness and training related to NBS. Findings indicated a significant demand among healthcare professionals for enhanced training and better access to informational resources about NBS, as well as improved education for families prior to childbirth.
Publications
View Publications at NCBI: